0

Scleroderma Collection
 1-20 of 79 Articles
Original Research |  18 February 2014
Treatment of Primary Sjögren Syndrome With Rituximab: A Randomized Trial
Valérie Devauchelle-Pensec, MD, PhD; Xavier Mariette, MD, PhD; Sandrine Jousse-Joulin, MD; et al.
Ann Intern Med. 2014;160(4):233-242. doi:10.7326/M13-1085
Original Research |  16 November 2010
Autologous Mesenchymal Stem Cells Foster Revascularization of Ischemic Limbs in Systemic Sclerosis: A Case Report
Serena Guiducci, MD; Francesco Porta, MD; Riccardo Saccardi, MD; et al.
Ann Intern Med. 2010;153(10):650-654. doi:10.7326/0003-4819-153-10-201011160-00007
Editorials |  16 March 2010
Propensity Score Adjustment With Multilevel Data: Setting Your Sites on Decreasing Selection Bias
Michael E. Griswold, PhD; A. Russell Localio, PhD; Cynthia Mulrow, MD, MSc, Senior Deputy Editor
Ann Intern Med. 2010;152(6):393-395. doi:10.7326/0003-4819-152-6-201003160-00010
Reviews |  2 February 2010
Narrative Review: Fibrotic Diseases: Cellular and Molecular Mechanisms and Novel Therapies
Joel Rosenbloom, MD, PhD; Susan V. Castro, PhD; Sergio A. Jimenez, MD
Ann Intern Med. 2010;152(3):159-166. doi:10.7326/0003-4819-152-3-201002020-00007
Reviews |  6 January 2004
Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis
Sergio A. Jimenez, MD; Chris T. Derk, MD
Ann Intern Med. 2004;140(1):37-50. doi:10.7326/0003-4819-140-2-200401200-00013
Articles |  20 June 2000
Cyclophosphamide Is Associated with Pulmonary Function and Survival Benefit in Patients with Scleroderma and Alveolitis
Barbara White, MD; Wendy C. Moore, MD; Fredrick M. Wigley, MD; et al.
Ann Intern Med. 2000;132(12):947-954. doi:10.7326/0003-4819-132-12-200006200-00004
Articles |  6 June 2000
Recombinant Human Relaxin in the Treatment of Scleroderma: A Randomized, Double-Blind, Placebo-Controlled Trial
James R. Seibold, MD; Joseph H. Korn, MD; Robert Simms, MD; et al.
Ann Intern Med. 2000;132(11):871-879. doi:10.7326/0003-4819-132-11-200006060-00004
Articles |  21 March 2000
Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease: A Randomized, Controlled Trial
David B. Badesch, MD; Victor F. Tapson, MD; Michael D. McGoon, MD; et al.
Ann Intern Med. 2000;132(6):425-434. doi:10.7326/0003-4819-132-6-200003210-00002
Ideas and Opinions |  1 January 1995
Modulation of Collagen Gene Expression: Its Relation to Fibrosis in Systemic Sclerosis and Other Disorders
John Varga, MD; Sergio A. Jimenez, MD
Ann Intern Med. 1995;122(1):60-62. doi:10.7326/0003-4819-122-1-199501010-00010
Articles |  1 July 1994
Pulmonary Function and Gastroesophageal Reflux in Systemic Sclerosis
Matthew B. Troshinsky, MD; Gregory C. Kane, MD; John Varga, MD; et al.
Ann Intern Med. 1994;121(1):6-10. doi:10.7326/0003-4819-121-1-199407010-00002
Articles |  1 February 1994
Intravenous Iloprost Infusion in Patients with Raynaud Phenomenon Secondary to Systemic Sclerosis: A Multicenter, Placebo-controlled, Double-Blind Study
Fredrick M. Wigley, MD; Robert A. Wise, MD; James R. Seibold, MD; et al.
Ann Intern Med. 1994;120(3):199-206. doi:10.7326/0003-4819-120-3-199402010-00004
Articles |  15 November 1993
Autoantibody Reactive with RNA Polymerase III in Systemic Sclerosis
Yutaka Okano, MD; Virginia D. Steen, MD; Thomas A. Medsger, MD
Ann Intern Med. 1993;119(10):1005-1013. doi:10.7326/0003-4819-119-10-199311150-00007
Articles |  15 April 1993
Early Undifferentiated Connective Tissue Disease: III. Outcome and Prognostic Indicators in Early Scleroderma (Systemic Sclerosis)
Ken J. Bulpitt, MD; Philip J. Clements, MD; Peter A. Lachenbruch, PhD; et al.
Ann Intern Med. 1993;118(8):602-609. doi:10.7326/0003-4819-118-8-199304150-00005
Articles |  15 September 1991
Natural History of the Eosinophilia-Myalgia Syndrome
Randall C. Culpepper, MD, MPH; Ronald G. Williams, MD, MPH; Philip J. Mease, MD; et al.
Ann Intern Med. 1991;115(6):437-442. doi:10.7326/0003-4819-115-6-437
Letters |  1 April 1991
Iloprost for Scleroderma
Thierry Constans, MD; Elisabeth Diot, MD; Gérard Lasfargues, MD
Ann Intern Med. 1991;114(7):606. doi:10.7326/0003-4819-114-7-606_1
Articles |  1 September 1990
Outcome of Renal Crisis in Systemic Sclerosis: Relation to Availability of Angiotensin Converting Enzyme (ACE) Inhibitors
Virginia D. Steen, MD; Joseph P. Costantino, DrPH; Alvin P. Shapiro, MD; et al.
Ann Intern Med. 1990;113(5):352-357. doi:10.7326/0003-4819-113-5-352
Articles |  15 May 1990
L-Tryptophan Ingestion Associated with Eosinophilic Fasciitis but Not Progressive Systemic Sclerosis
Bruce Freundlich, MD; Victoria P. Werth, MD; Alain H. Rook, MD; et al.
Ann Intern Med. 1990;112(10):758-762. doi:10.7326/0003-4819-112-10-758
Articles |  1 March 1990
Development of Diffuse Fasciitis with Eosinophilia during L-Tryptophan Treatment: Demonstration of Elevated Type I Collagen Gene Expression in Affected Tissues: A Clinicopathologic Study of Four Patients
John Varga, MD; Juha Peltonen, MD, PhD; Jouni Uitto, MD, PhD; et al.
Ann Intern Med. 1990;112(5):344-351. doi:10.7326/0003-4819-112-5-344
Articles |  1 September 1989
Systemic Sclerosis after Augmentation Mammoplasty with Silicone Implants
John Varga, MD; H. Ralph Schumacher, MD; Sergio A. Jimenez, MD
Ann Intern Med. 1989;111(5):377-383. doi:10.7326/0003-4819-111-5-377
Articles |  15 March 1989
Interleukin-2 in Scleroderma: Correlation of Serum Level with Extent of Skin Involvement and Disease Duration
M. Bashar Kahaleh, MD; Carwile E. LeRoy, MD
Ann Intern Med. 1989;110(6):446-450. doi:10.7326/0003-4819-110-6-446
Advertisement

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)